Bridger Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Bridger Management, LLC

  • $196 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$544.75 - $658.21 $30.5 Million - $36.9 Million
-56,053 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$493.32 - $643.92 $17.6 Million - $23 Million
-35,744 Reduced 38.94%
56,053 $35 Million
Q1 2020

May 15, 2020
BUY
$336.18 - $494.43 $30.9 Million - $45.4 Million
91,797 New
91,797 $44.8 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Bridger Management, LLC Portfolio

Follow Bridger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridger Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email